The University of Alabama at Birmingham General Clinical Research Center is a multi-disciplinary facility available to faculty members of the Schools of Medicine and Dentistry for the pursuit of clinical investigation. The GCRC and its staff facilitate the meticulous control of experimental conditions, close observation and accurate monitoring of biologic phenomena, and the precise measurement of biochemical and physiological events which occur in patients and normal volunteers participating in research activities. In order to increase the efficiency and productivity of research efforts on individually funded projects, afford participants more flexibility in taking new research directions, and promoter more collaborative research among groups having multi- disciplinary approaches to science, we have negotiated construction of a new facility with University Hospital. This will include both inpatient and outpatient facilities as well as a processing laboratory and a Gene Therapy Core Laboratory in a discrete area on the ninth floor of the Medical Education Building, adjacent to the West Pavilion inpatient rooms. The Gene Therapy CORE will complement the UAB Gene Therapy/Vaccine Vector Core as well as address gene therapy needs for the present and anticipated future years. A separated suite of rooms which will house the CDMAS facility and offices for biostatisticians and coordinators will be located on the second floor of the same building directly below the GCRC unit and accessible via an elevator. In addition to the facilities listed above, this application includes a request for support for a Physiology and Metabolism Core Laboratory Facility, housed in the existing Energy Metabolism Research Unit in the Department of Nutrition Sciences. The proposed Physiology and Metabolism Core will provide access to expertise in the measurement and interpretation of physiological and provide access to expertise in the measurement and interpretation and of physiological and provide access to expertise in the measurement and interpretation of physiological and biochemical parameters essential conducting base clinical whole-body metabolic research for GCRC approved investigators. Changes in the GCRC facility will accommodate existing research activities as well as the perceived new emphasis on gene therapy.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000032-39
Application #
2797031
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Beitins, Inese Z
Project Start
1978-12-01
Project End
2002-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
39
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Morrison, Shannon A; Goss, Amy M; Azziz, Ricardo et al. (2017) Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome. Hum Reprod 32:185-192
Shen, Chengli; Landsittel, Douglas; Irazabal, María V et al. (2017) Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis 69:482-484
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
Kline, Timothy L; Korfiatis, Panagiotis; Edwards, Marie E et al. (2017) Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int 92:1206-1216
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445

Showing the most recent 10 out of 570 publications